4/A
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-20-000002
CEO bought 5,700 shares at an average $0.03 ($163)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2019-12-10 | Purchase | +2,000 | $0.00 | $6 | 25,414,997 | D |
| Collier Alan Brian CEO | 2019-12-10 | Purchase | +1,000 | $0.00 | $3 | 25,415,997 | D |
| Collier Alan Brian CEO | 2019-12-11 | Purchase | +1,000 | $0.00 | $2 | 25,416,997 | D |
| Collier Alan Brian CEO | 2019-12-11 | Purchase | +100 | $0.00 | $0 | 25,417,097 | D |
| Collier Alan Brian CEO | 2019-12-12 | Purchase | +1,000 | $0.00 | $2 | 25,418,097 | D |
| Collier Alan Brian CEO | 2019-12-16 | Purchase | +500 | $0.00 | $1 | 25,418,597 | D |
| Collier Alan Brian CEO | 2019-12-20 | Purchase | +100 | $1.50 | $150 | 25,519 | D |
| Open-market purchases · 5,700 sh · avg $0.03 · $163 | |||||||
Loading xslF345X03/primary_doc.xml…